01/29/2026
🎗️ Q&A | HER2-Positive Breast Cancer Care 🎗️
❓ What happens if a complete response is not achieved in HER2-positive breast cancer?
✅ If cancer cells remain after initial treatment, medicines like KADCYLA (T-DM1) may be recommended to reduce the risk of recurrence and improve long-term outcomes—based on individual patient needs.
Making the right treatment decision at the right time can make a real difference. 💗
Stay informed. Ask questions. Choose personalised care.
📲 Get FREE breast cancer consultation on WhatsApp: (704) 974-1437